In contrast, the subgroups without T2D and with tumours showed a trend of reduced risk of any kidney event in the rapid eGFRdec group compared with the reference group: 0.9 (0.4 to 1.8) in the subgroup without T2D; 0.5 (0.2 to 1.3) in the subgroup with tumours ( online supplemental table 2 ).
← all excerpts
Analysis of eGFR index category and annual eGFR slope association with adverse clinical outcomes using real-world Japanese data: a retrospective database study.
1
—
—